Startseite Fifteen polymorphisms in endothelin-1, endothelin-2 and endothelin-receptor-A genotyped by four duplex assays and seven simple assays on a LightCycler using hybridization probes
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Fifteen polymorphisms in endothelin-1, endothelin-2 and endothelin-receptor-A genotyped by four duplex assays and seven simple assays on a LightCycler using hybridization probes

  • Farhad Arjomand-Nahad , Olfert Landt , Karl Stangl , Konstanze Diefenbach und Ivar Roots
Veröffentlicht/Copyright: 21. September 2011
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Endothelins (EDNs) are peptides, produced by various tissues, with potent vasoactive and mitogenic properties. Endothelin actions are mediated via specific G protein-coupled receptors of two subtypes, endothelin-receptor-A (EDNRA) and endothelin-receptor-B (EDNRB). Some polymorphisms of the EDN1, EDN2 and EDNRA genes may influence susceptibility to vascular diseases. Thus, genotyping for polymorphisms of these genes may represent a tool for predicting individual susceptibility to vascular diseases. Here, we report 11 fluorescence resonance energy transfer (FRET) assays for the detection of 15 polymorphisms, because the assays used in previous studies (allele-specific PCR and restriction fragment-length polymorphism assays) for some of these polymorphisms are laborious and time-consuming. The newly developed assays are fast and work without expensive ready-to-use mixtures.

Clin Chem Lab Med 2006;44:929–32.


Corresponding author: Farhad Arjomand-Nahad, Institute of Clinical Pharmacology, Campus Charité Mitte, Charité University Medical Center, Schumannstr. 20/21, 10117 Berlin, Germany Phone: +49-30-450525275, Fax: +49-30-450525926,

References

1. Kedzierski RM, Yanagisawa M. Endothelin system: the double-edged sword in health and disease. Annu Rev Pharmacol Toxicol 2001; 41:851–76.10.1146/annurev.pharmtox.41.1.851Suche in Google Scholar

2. Sharma P, Lu F, Rut A, Brown MJ. Structure of human endothelin-2 gene and demonstration of common expression in human right atrial tissue. Biochem Biophys Res Commun 1998; 245:709–12.10.1006/bbrc.1998.8507Suche in Google Scholar

3. Nicaud V, Poirier O, Behague I, Herrmann SM, Mallet C, Troesch A, et al. Polymorphisms of the endothelin-A and -B receptor genes in relation to blood pressure and myocardial infarction: the Etude Cas-Temoins sur l'Infarctus du Myocarde (ECTIM) Study. Am J Hypertens 1999; 12:304–10.10.1016/S0895-7061(98)00255-6Suche in Google Scholar

4. Sharma P, Hingorani A, Jia H, Hopper R, Brown MJ. Quantitative association between a newly identified molecular variant in the endothelin-2 gene and human essential hypertension. J Hypertens 1999; 17:1281–7.10.1097/00004872-199917090-00007Suche in Google Scholar PubMed

5. Brown MJ, Sharma P, Stevens PA. Association between diastolic blood pressure and variants of the endothelin-1 and endothelin-2 genes. J Cardiovasc Pharmacol 2000; 35:S41–3.10.1097/00005344-200000002-00010Suche in Google Scholar PubMed

6. Wittwer CT, Herrmann MG, Moss AA, Rasmussen RP. Continuous fluorescence monitoring of rapid cycle DNA amplification. Biotechniques 1997; 22:130–8.10.2144/97221bi01Suche in Google Scholar PubMed

Received: 2006-3-20
Accepted: 2006-5-8
Published Online: 2011-9-21
Published in Print: 2006-8-1

©2006 by Walter de Gruyter Berlin New York

Artikel in diesem Heft

  1. Laboratory medicine in the 2000s: programmed death or rebirth?
  2. Polymorphisms of the inflammatory system and risk of ischemic cerebrovascular events
  3. Haptoglobin polymorphism in patients with preeclampsia
  4. Fifteen polymorphisms in endothelin-1, endothelin-2 and endothelin-receptor-A genotyped by four duplex assays and seven simple assays on a LightCycler using hybridization probes
  5. Optimization of an enzymatic method for the determination of lysosomal N-acetyl-β-D-hexosaminidase and β-glucuronidase in synovial fluid
  6. An improved laboratory protocol to assess subarachnoid haemorrhage in patients with negative cranial CT scan
  7. Association of aminothiols with the clinical outcome in hemodialysis patients: comparison of chromatography and immunoassay for homocysteine determination
  8. Poor prognosis indicated by nucleated red blood cells in peripheral blood is not associated with organ failure of the liver or kidney
  9. Detection of citrate overdose in critically ill patients on citrate-anticoagulated venovenous haemofiltration: use of ionised and total/ionised calcium
  10. Unchanged androgen-binding properties of sex hormone-binding globulin in male patients with liver cirrhosis
  11. Relationship between serum uric acid, creatinine, albumin and gestational diabetes mellitus
  12. Aminothiols in human brain tumors
  13. Measurement of carnitine in hemodialysis patients – adaptation of an enzymatic photometric method for an automatic analyzer
  14. A robust liquid chromatography tandem mass spectrometry method for total plasma homocysteine determination in clinical practice
  15. Establishment of reference distributions and decision values for thyroid antibodies against thyroid peroxidase (TPOAb), thyroglobulin (TgAb) and the thyrotropin receptor (TRAb)
  16. Effects of a long-distance run on cardiac markers in healthy athletes
  17. α-Tocopherol supplementation reduces the elevated 8-hydroxy-2-deoxyguanosine blood levels induced by training in basketball players
  18. Influence of the needle bore size used for collecting venous blood samples on routine clinical chemistry testing
  19. The ratio of apoB/apoAI, apoB and lipoprotein(a) are the best predictors of stable coronary artery disease
  20. Evaluation of the analytical performance of the advanced method for cardiac troponin I for the AxSYM platform: comparison with the old method and the Access system
  21. Preliminary performance evaluation of blood gas analyzers
  22. A cost-effectiveness evaluation of reticulocyte measurement in new outpatients with or without hematologic disorders
  23. Guidelines for setting up an External Quality Assessment Scheme for blood smear interpretation. Part II: survey preparation, statistical evaluation and reporting
  24. Free light chain testing in follow-up of multiple myeloma
  25. Blood reactive oxygen metabolites (ROMs) and total antioxidant status (TAS) in patients with laryngeal squamous cell carcinoma after surgical treatment
  26. SIBioC 2006 38th National Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology, Turin, Italy, September 19–22, 2006
  27. Third Santorini Biologie Prospective Conference 2006: From Human Genetic Variations to Prediction of Risks and Responses to Drugs and the Environment, Santorini Island, Greece, September 29 - October 2, 2006
Heruntergeladen am 18.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2006.180/html
Button zum nach oben scrollen